Canagliflozin and Metformin Extended-Release Tablets and Mogamulizumab
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Mogamulizumab-kpkc
- Canagliflozin and Metformin Extended-Release Tablets-Mogamulizumab-kpkc Intravenous
- Canagliflozin and Metformin Extended-Release Tablets-Molindone
- Canagliflozin and Metformin Extended-Release Tablets-Mometasone (Oral Inhalation)
- Canagliflozin and Metformin Extended-Release Tablets-Mometasone and Formoterol
- Canagliflozin and Metformin Extended-Release Tablets-Mometasone and formoterol Inhalation
- Mogamulizumab-Canagliflozin and Metformin Tablets
- Mogamulizumab-Canakinumab
- Mogamulizumab-Canakinumab Subcutaneous
- Mogamulizumab-Canasa
- Mogamulizumab-Canasa Pac rectal
- Mogamulizumab-Canasa rectal